Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K J Pienta

Showing results (51-60 of 142) with videos related to

Pageof 15
Sort By:
Mechanisms of Ageing and Development|January 1, 1992
Characterization of nuclear morphology and nuclear matrices in ageing human fibroblastsK J Pienta, R H Getzenberg, D S Coffey
The Urologic Clinics of North America|June 11, 1999
Rational use of chemotherapy. It is not just rat poisonJ M Kamradt, E A Klein, K J Pienta
The Urologic Clinics of North America|June 11, 1999
Oral chemotherapy for hormone refractory prostate cancer. The University of Michigan experienceJ M Kamradt, D C Smith, K J Pienta
The Prostate|January 1, 1992
Effects of extracellular matrix components and dihydrotestosterone on the structure and function of human prostate cancer cellsB C Murphy, K J Pienta, D S Coffey
Critical Reviews in Eukaryotic Gene Expression|January 1, 1991
Cell structure and DNA organizationK J Pienta, R H Getzenberg, D S Coffey
Endocrine Reviews|August 1, 1990
The tissue matrix: cell dynamics and hormone actionR H Getzenberg, K J Pienta, D S Coffey
Biochemical and Biophysical Research Communications|December 5, 1995
Galectin-3 is a nuclear matrix protein which binds RNAL Wang, H Inohara, K J Pienta, et al.
Anticancer Research|November 1, 1993
Pentosan inhibits angiogenesis in vitro and suppresses prostate tumor growth in vivoN M Nguyen, J E Lehr, K J Pienta
Urology|August 12, 1999
Use of PC-SPES, a commercially available supplement for prostate cancer, in a patient with hormone-naive diseaseM A Moyad, K J Pienta, J E Montie
Urology|February 22, 2001
Different docetaxel-induced apoptotic pathways are present in prostate cancer cell lines LNCaP and PC-3H J Muenchen, P J Poncza, K J Pienta
Pageof 15

Showing results (51-60 of 142) with videos related to

Sort By:
Pageof 15
Mechanisms of Ageing and Development|January 1, 1992
Characterization of nuclear morphology and nuclear matrices in ageing human fibroblastsK J Pienta, R H Getzenberg, D S Coffey
The Urologic Clinics of North America|June 11, 1999
Rational use of chemotherapy. It is not just rat poisonJ M Kamradt, E A Klein, K J Pienta
The Urologic Clinics of North America|June 11, 1999
Oral chemotherapy for hormone refractory prostate cancer. The University of Michigan experienceJ M Kamradt, D C Smith, K J Pienta
The Prostate|January 1, 1992
Effects of extracellular matrix components and dihydrotestosterone on the structure and function of human prostate cancer cellsB C Murphy, K J Pienta, D S Coffey
Critical Reviews in Eukaryotic Gene Expression|January 1, 1991
Cell structure and DNA organizationK J Pienta, R H Getzenberg, D S Coffey
Endocrine Reviews|August 1, 1990
The tissue matrix: cell dynamics and hormone actionR H Getzenberg, K J Pienta, D S Coffey
Biochemical and Biophysical Research Communications|December 5, 1995
Galectin-3 is a nuclear matrix protein which binds RNAL Wang, H Inohara, K J Pienta, et al.
Anticancer Research|November 1, 1993
Pentosan inhibits angiogenesis in vitro and suppresses prostate tumor growth in vivoN M Nguyen, J E Lehr, K J Pienta
Urology|August 12, 1999
Use of PC-SPES, a commercially available supplement for prostate cancer, in a patient with hormone-naive diseaseM A Moyad, K J Pienta, J E Montie
Urology|February 22, 2001
Different docetaxel-induced apoptotic pathways are present in prostate cancer cell lines LNCaP and PC-3H J Muenchen, P J Poncza, K J Pienta
Pageof 15